[1]王嫄嫄,陈洪波.病毒性肝炎肝硬化患者血清干扰素α2a、5'-核苷酸酶、天冬氨酸转氨酶/丙氨酸转氨酶水平变化与肝储备功能关系及其对合并腹水的预测价值[J].陕西医学杂志,2025,54(3):369-373.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.016]
　WANG Yuanyuan,CHEN Hongbo.Relationship between serum levels of interferon IFN-α2a、5'-NT、AST/ALT and liver reserve function in patients with viral hepatitis and cirrhosis and their predictive value for ascites[J].,2025,54(3):369-373.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.016]
点击复制

病毒性肝炎肝硬化患者血清干扰素α2a、5'-核苷酸酶、天冬氨酸转氨酶/丙氨酸转氨酶水平变化与肝储备功能关系及其对合并腹水的预测价值
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年3期
页码:
369-373
栏目:
临床研究
出版日期:
2025-03-05

文章信息/Info

Title:
Relationship between serum levels of interferon IFN-α2a、5'-NT、AST/ALT and liver reserve function in patients with viral hepatitis and cirrhosis and their predictive value for ascites
作者:
王嫄嫄; 陈洪波
(邢台市中心医院,河北 邢台 054000)
Author(s):
WANG Yuanyuan; CHEN Hongbo
(Xingtai Central Hospital,Xingtai 054000,China)
关键词:
病毒性肝炎肝硬化;  干扰素α2a;  5'-核苷酸酶;  天冬氨酸转氨酶/丙氨酸转氨酶;  肝储备功能;  腹水;  预测价值
Keywords:
Viral hepatitis and cirrhosis;  Interferon-α2a;  5'-nucleotidase;  Aspartate aminotransferase/alanine aminotransferase;  Liver reserve function;  Ascites;  Predictive value
分类号:
R 512.6
DOI:
DOI:10.3969/j.issn.1000-7377.2025.03.016
文献标志码:
A
摘要:
目的:探究病毒性肝炎肝硬化患者血清干扰素α2a(IFN-α2a)、5'-核苷酸酶(5'-NT)、天冬氨酸转氨酶/丙氨酸转氨酶(AST/ALT)水平变化与肝储备功能的关系及其对合并腹水的预测价值。方法:纳入病毒性肝炎肝硬化患者85例为研究组,纳入同期体检健康者85例为对照组。比较两组肝功能指标[AST、ALT、白蛋白(ALB)、总胆红素(STB)]、肝储备功能指标[吲哚菁绿15 min滞留率(ICGR15)、肝有效血流量(EHBF)、肝功能CTP评分]以及IFN-α2a、5'-NT、AST/ALT水平。分析IFN-α2a、5'-NT、AST/ALT水平与肝储备功能指标的相关性。根据患者是否合并腹水将研究组患者分为无腹水组和腹水组,比较两组上述指标。分析IFN-α2a、5'-NT、AST/ALT对病毒性肝炎肝硬化患者合并腹水的预测价值。结果:与对照组比较,研究组AST、ALT、STB、ICGR15、IFN-α2a、5'-NT、AST/ALT水平和CTP评分升高,ALB、EHBF水平降低(均P<0.05)。IFN-α2a、5'-NT、AST/ALT水平与ICGR15、CTP评分呈正相关,与EHBF呈负相关(均P<0.05)。85例患者中,未合并腹水54例(无腹水组),合并腹水31例(腹水组)。与无腹水组比较,腹水组ICGR15、IFN-α2a、5'-NT、AST/ALT水平和CTP评分升高,ALB、EHBF水平降低(均P<0.05)。IFN-α2a、5'-NT、AST/ALT对病毒性肝炎肝硬化合并腹水有较高的预测价值,三项联合检测的预测价值更高(均P<0.05)。结论:病毒性肝炎肝硬化患者血清IFN-α2a、5'-NT、AST/ALT水平升高,与肝储备功能具有相关性,三项联合检测对合并腹水亦有良好的预测价值。
Abstract:
Objective:To investigate the relationship between serum levels of interferon α2a(IFN-α2a),5'-nucleotidase(5' -NT),aspartate aminotransferase/alanine aminotransferase(AST/ALT)and liver reserve function in patients with viral hepatitis and cirrhosis and their predictive value for ascites.Methods:85 patients with viral hepatitis and cirrhosis were included in the study group,and 85 healthy subjects were included as control group.Liver function indexes(AST,ALT,ALB,STB),liver reserve function indexes(ICGR15,EHBF,liver function CTP score)and IFN-α2a,5'-NT,AST/ALT levels were compared between the two groups.The correlations between IFN-α2a,5'-NT,AST/ALT levels and liver reserve function were analyzed.According to whether patients with ascites or not,the study group was divided into non-ascites group and ascites group,and the above indexes were compared between the two groups.The predictive value of IFN-α2a,5'-NT,AST/ALT for ascites in patients with viral hepatitis and cirrhosis was analyzed.Results:Compared with the control group,AST,ALT,STB,ICGR15,IFN-α2a,5'-NT,AST/ALT levels and CTP score were increased in the study group,while ALB and EHBF levels were decreased(all P<0.05).IFN-α2a,5'-NT,AST/ALT levels were positively correlated with ICGR15 and CTP scores,and were negatively correlated with EHBF(all P<0.05).Among the 85 patients,there were 54 cases without ascites(non-ascites group)and 31 cases with ascites(ascites group).Compared with non-ascites group,ICGR15,IFN-α2a,5'-NT,AST/ALT levels and CTP score were increased in ascites group,while ALB and EHBF levels were decreased(all P<0.05).IFN-α2a,5'-NT,AST/ALT had high predictive value for viral hepatitis and cirrhosis complicated with ascites,and the three combined tests had higher predictive value(all P<0.05).Conclusion:The levels of serum IFN-α2a,5'-NT and AST/ALT in patients with viral hepatitis and cirrhosis are increased,which are correlated with liver reserve function,and the combined detection of three also has good predictive value for ascites.

参考文献/References:

[1] 丁红燕,韩文静,杨明兆.老年病毒性肝炎125例病原学分析[J].陕西医学杂志,2001,30(10):612-613.
[2] 宋咪,宣昊,顾子杨,等.2011—2020年武威市丙型病毒性肝炎流行病学特征分析[J].空军军医大学学报,2024,45(5):526-530,536.
[3] ZHAO H,ZHU P,HAN T,et al.Clinical characteristics analysis of 1180 patients with hepatocellular carcinoma secondary to hepatitis B,hepatitis C and alcoholic liver disease[J].J Clin Lab Anal,2020,34(2):e23075.
[4] 郑玲玲,孟银梅,刘南南,等.阜阳市丙型病毒性肝炎流行病学特点及疾病进展影响因素[J].实用临床医药杂志,2022,26(12):61-64.
[5] 韩静,肖丽,张会,等.EB病毒性肝炎40例临床分析[J].实用临床医药杂志,2018,22(5):23-25.
[6] 黄澳迪,唐林,王晓琪,等.中国2011-2021年戊型病毒性肝炎发病趋势和时空聚集性[J].中国疫苗和免疫,2022,28(4):417-421.
[7] 阚晓,隋赟,韩绍磊,等.聚乙二醇化干扰素α-2a对慢性乙型肝炎患者外周血T淋巴细胞亚群的影响[J].基础医学与临床,2011,31(10):1139-1143.
[8] 郑泽星,邓立婷,孙海宇,等.超声诊断原发性胆汁性肝硬化与病毒性肝炎肝硬化结果分析[J].深圳中西医结合杂志,2021,31(15):97-98.
[9] HUANG X,YAO L,DENG Z R,et al.Analysis of clinical characteristics of 481 HBV-related liver cirrhotic patients with low viral load[J].Zhonghua Gan Zang Bing Za Zhi,2021,29(3):227-233.
[10] OH J H,PARK Y,GOH M J,et al.Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B[J].Sci Rep,2023,13(1):9443.
[11] RIAZ H A,NISHWA D E,FATIMA A,et al.Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis[J].Heliyon,2023,9(5):e16169.
[12] HOWELL J,VAN H,PHAM M,et al.Validation of novel point-of-care test for alanine aminotransferase measurement:A pilot cohort study[J].Clin Liver Dis(Hoboken),2022,20(4):136-139.
[13] 范丽,张婷.拉米夫定、阿德福韦酯、恩替卡韦治疗失代偿期乙型肝炎肝硬化临床研究[J].陕西医学杂志,2019,48(7):939-941.
[14] 徐凤玲,吕江峰,庄伟,等.病毒性肝炎临床检测指标的诊断分析[J].中华医院感染学杂志,2016,26(19):4362-4364.
[15] 中国戊型肝炎研究协助组,中国医师协会感染科医师分会,国家感染性疾病临床医学研究中心.中国戊型病毒性肝炎院内筛查管理流程专家共识(2023年版)[J].临床肝胆病杂志,2023,39(4):785-794.
[16] 谢旭,李国焕,贾文燕,等.参芪软肝汤配合抗病毒药物治疗肝硬化临床研究[J].陕西中医,2024,45(6):771-774.
[17] 曾碧雨,姚春,陈月桥,等.中医药治疗乙型肝炎肝硬化失代偿期研究进展[J].陕西中医,2024,45(6):850-854.
[18] 黄志远,邹蕾,李娇,等.急性药物性肝损伤患者血清核因子E2相关因子2、血红素加氧酶-1、脂肪酸结合蛋白4、缺氧诱导因子1α表达意义及其与肝功能指标相关性研究[J].陕西医学杂志,2024,53(7):983-986.
[19] ZHANG D,PAN Y,YANG Z,et al.A Nomogram based on preoperative lab tests,BMI,ICG-R15,and EHBF for the prediction of post-hepatectomy liver failure in patients with hepatocellular carcinoma[J].J Clin Med,2022,12(1):324.
[20] SOBALA-SZCZYGIE B,BORON-KACZMARSKA A,KEPA L,et al.Acute liver failure during treatment of interferon alpha 2a chronic hepatitis B and coinfection of parvovirus B19[J].Przegl Epidemiol,2016,70(3):444-448.
[21] 冯小丽,张运希,唐伟.聚乙二醇干扰素α-2a对HBV/HCV重叠感染患者疗效、肝功能及炎性因子的影响[J].辽宁医学杂志,2022,36(6):33-36.
[22] 王茸,张淼,丁蕾,等.甲型肝炎患者外周血sIL-2R、炎前因子、IFN-α2a水平变化[J].中国伤残医学,2014,22(5):39-41.
[23] 孟淑慧,胥莹,邹松龙,等.凝血酶原国际标准化比值/白蛋白对失代偿期肝硬化患者预后的预测价值[J].临床肝胆病杂志,2021,37(9):2081-2086.
[24] 陈毅然,张文富.基于分段论治理论治疗肝硬化腹水研究进展[J].陕西中医,2023,44(10):1487-1490.
[25] BISWAS S,KUMAR R,ACHARYA S K,et al.Prognostic scores in acute liver failure due to viral hepatitis[J].Diagnostics(Basel),2023,13(6):1035.

备注/Memo

备注/Memo:
[基金项目] 河北省医学科学研究课题(202015631)
更新日期/Last Update: 2025-03-05